Graypoint LLC Regeneron Pharmaceuticals, Inc. Transaction History

Graypoint LLC

$1.56 Billion
Q1 2025

A detailed history of Graypoint LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Graypoint LLC holds 2,015 shares of REGN stock, worth $1.2 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

2,015

Previous 2,108 4.41%

Holding current value

$1.2 Million

Previous $1.5 Million 14.92%

% of portfolio

0.08%

Previous 0.09%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 02, 2025	SELL	$634.14 - $744.83 $58,975 - $69,269	-93 Reduced 4.41%	2,015 $1.28 Million
Q4 2024 Jan 10, 2025	SELL	$701.85 - $1046.91 $167,040 - $249,164	-238 Reduced 10.14%	2,108 $1.5 Million
Q3 2024 Oct 31, 2024	BUY	$1024.09 - $1201.76 $77,830 - $91,333	76 Added 3.35%	2,346 $2.47 Million
Q2 2024 Jul 31, 2024	BUY	$883.2 - $1071.19 $120,115 - $145,681	136 Added 6.37%	2,270 $2.39 Million
Q1 2024 May 02, 2024	BUY	$902.69 - $993.35 $37,912 - $41,720	42 Added 2.01%	2,134 $2.05 Million
Q4 2023 Jan 29, 2024	BUY	$775.18 - $881.7 $36,433 - $41,439	47 Added 2.3%	2,092 $1.84 Million
Q3 2023 Oct 26, 2023	SELL	$692.45 - $844.37 $103,867 - $126,655	-150 Reduced 6.83%	2,045 $1.68 Million
Q2 2023 Jul 21, 2023	SELL	$700.03 - $830.35 $157,506 - $186,828	-225 Reduced 9.3%	2,195 $1.58 Million
Q1 2023 May 02, 2023	BUY	$680.49 - $826.97 $970,378 - $1.18 Million	1,426 Added 143.46%	2,420 $1.99 Million
Q4 2022 Jan 31, 2023	BUY	$705.89 - $766.39 $44,471 - $48,282	63 Added 6.77%	994 $717,000
Q3 2022 Oct 31, 2022	BUY	$573.97 - $724.32 $33,290 - $42,010	58 Added 6.64%	931 $641,000
Q2 2022 Aug 01, 2022	SELL	$548.35 - $738.84 $19,192 - $25,859	-35 Reduced 3.85%	873 $516,000
Q1 2022 Apr 19, 2022	BUY	$595.12 - $698.43 $45,229 - $53,080	76 Added 9.13%	908 $634,000
Q4 2021 Jan 31, 2022	BUY	$543.48 - $670.97 $39,130 - $48,309	72 Added 9.47%	832 $525,000
Q3 2021 Nov 09, 2021	BUY	$574.03 - $680.96 $4,018 - $4,766	7 Added 0.93%	760 $460,000
Q2 2021 Aug 04, 2021	BUY	$472.8 - $558.54 $31,204 - $36,863	66 Added 9.61%	753 $421,000
Q1 2021 May 07, 2021	BUY	$446.73 - $548.2 $9,828 - $12,060	22 Added 3.31%	687 $325,000
Q4 2020 Feb 05, 2021	SELL	$478.3 - $607.98 $10,522 - $13,375	-22 Reduced 3.2%	665 $321,000
Q3 2020 Nov 02, 2020	BUY	$544.75 - $658.21 $13,618 - $16,455	25 Added 3.78%	687 $385,000
Q1 2020 Apr 30, 2020	BUY	$336.18 - $494.43 $222,551 - $327,312	662 New	662 $323,000

Others Institutions Holding REGN

# of Institutions

1,470

Shares Held

85.8M

Call Options Held

1.39M

Put Options Held

1.45M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $63.7B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Graypoint LLC, based on Form 13F filings with the SEC.

News

Stay updated on Graypoint LLC with notifications on news.

Account